Casa di Cura Privata del Policlinico SpA Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2020
NCT04654741
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Casa di Cura Privata del Policlinico SpA | Casa di Cura Privata Policlinico (CCPP) | Casa di Cura Privata Villa Mafalda

Active Ingredients

Drugs in Phase 4 Trials (3)

desogestrel (Mercilon) (1 trial)

ganirelix (2 trials)

medroxyprogesterone (provera) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Infertility (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3